Prevacid 24HR Hits Shelves, Targets Rx-Users And Fed-Up Heartburn Sufferers
This article was originally published in The Tan Sheet
Executive Summary
Novartis supports the Nov. 12 launch of over-the-counter proton pump inhibitor Prevacid 24HR with what the firm calls its "largest OTC product launch campaign to date.
You may also be interested in...
Perrigo Squares Off With Dr. Reddy’s In Lansoprazole Launch
U.S. FDA denied Perrigo’s petition that had sought to block Dr. Reddy’s ANDA for generic Prevacid 24HR because it used bioequivalence data for the proton pump inhibitor’s Rx version. Competition between the firms is intensifying as Dr. Reddy’s expands its U.S. OTC presence.
Perrigo Squares Off With Dr. Reddy’s In Lansoprazole Launch
U.S. FDA denied Perrigo’s petition that had sought to block Dr. Reddy’s ANDA for generic Prevacid 24HR because it used bioequivalence data for the proton pump inhibitor’s Rx version. Competition between the firms is intensifying as Dr. Reddy’s expands its U.S. OTC presence.
Perrigo Squares Off With Dr. Reddy’s In Lansoprazole Launch
FDA denied Perrigo’s petition that had sought to block Dr. Reddy’s ANDA for generic Prevacid 24HR because it used bioequivalence data for the proton pump inhibitor’s Rx version. Competition between the firms is intensifying as Dr. Reddy’s expands its U.S. OTC presence.